Table 2. The effect of GDF11 on cell viability, cell proliferation and cell migration in different endothelial cells.
Cell type | culture condition | GDF11 (concentration/time) | cell viability | cell proliferation | cell migration | Ref. |
---|---|---|---|---|---|---|
brain capillary endothelial cells | 5% FBS (VEGF;EGF) | 40 ng/mL 6 days | + | [3] | ||
endothelial progenitor cells | 10% FBS | 40 ng/mL 3 days | none | [96] | ||
endothelial progenitor cells | 10% FBS | 40 ng/mL 1 h | [96] | |||
endothelial progenitor cells | Without FBS | 40 ng/mL 1 day | + | [96] | ||
human umbilical endothelial cells | 10% FBS | 50 ng/mL | none | none | none | [23] |
rat aortic endothelial cells | 10% FBS | 50 ng/mL | none | none | none | [23] |
human umbilical endothelial cells | Without FBS | 50 ng/mL | + | [23] | ||
mice aortic endothelial cells | unknown | 50 ng/mL 1 or 3 days | none | [27] | ||
mice aortic endothelial cells | unknown | 50 ng/mL 5 days | + | [27] | ||
mice aortic endothelial cells | unknown | unknown | none | [27] |
+:promotion; none:no significant effect.